Therapeutic monitoring of mycophenolic acid
Authors:
- Andrew NichollsANAndrew Nicholls
- Michael HaleMHMichael Hale
- Victor W ArmstrongVAVictor W Armstrong
- Michael OellerichMOMichael Oellerich
- Randy YatscoffRYRandy Yatscoff
- Randall E MorrisRMRandall E Morris
- David W HoltDHDavid W Holt
- Raman VenkataramananRVRaman Venkataramanan
- Jane HaleyJHJane Haley
- Philip HalloranPHPhilip Halloran
- Robert EttengerRERobert Ettenger
Open Access
- 1 July 1998
- journal article
- review article
- Published by Elsevier in Clinical Biochemistry
- Vol. 31 (5) , 317-322
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- 41 VALIDATION OF BEHRING DIAGNOSTICS EMIT® TO MEASURE MYCOPHENOLIC ACID IN HUMAN PLASMATherapeutic Drug Monitoring, 1997
- Kinetic Mechanism of Human Inosine 5‘-Monophosphate Dehydrogenase Type II: Random Addition of Substrates and Ordered Release of ProductsBiochemistry, 1997
- PHARMACODYNAMIC ASSESSMENT OF MYCOPHENOLIC ACIDINDUCED IMMUNOSUPPRESSION IN RENAL TRANSPLANT RECIPIENTSTransplantation, 1996
- Conformational Changes and Stabilization of Inosine 5′-Monophosphate Dehydrogenase Associated with Ligand Binding and Inhibition by Mycophenolic AcidJournal of Biological Chemistry, 1996
- Effects of food and antacid on the pharmacokinetics of single doses of mycophenolate mofetil in rheumatoid arthritis patientsBritish Journal of Clinical Pharmacology, 1996
- Pharmacokinetics and Bioavailability of Mycophenolate Mofetil in Healthy Subjects after Single‐Dose Oral and Intravenous AdministrationThe Journal of Clinical Pharmacology, 1996
- Mechanism of Action of Mycophenolate MofetilTherapeutic Drug Monitoring, 1995
- Blood Distribution of Mycophenolic AcidTherapeutic Drug Monitoring, 1994
- STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENTThe Lancet, 1986
- Alteration of Drug-Protein Binding in Renal DiseaseClinical Pharmacokinetics, 1984